# Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

> **NCT06574087** · NA · RECRUITING · sponsor: **PCK Marine Hospital in Gdynia** · enrollment: 248 (estimated)

## Conditions studied

- HPV-Related Carcinoma
- HPV Infection

## Interventions

- **DIAGNOSTIC_TEST:** hrHPV test and cytology

## Key facts

- **NCT ID:** NCT06574087
- **Lead sponsor:** PCK Marine Hospital in Gdynia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-13
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06574087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06574087, "Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06574087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*